Xenetic Biosciences Inc.

NASDAQ: XBIO · Real-Time Price · USD
2.86
-0.06 (-2.22%)
At close: Aug 15, 2025, 3:58 PM
2.96
3.50%
After-hours: Aug 15, 2025, 06:02 PM EDT

Xenetic Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.45M 2.58M 2.5M 2.52M 2.52M 2.44M 2.54M 2.35M 2.16M 1.92M 1.71M 1.55M 1.49M 1.36M 1.16M 979.42K 746.09K 571.41K
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 7.96K 17.57K 17.57K 26.85K 18.89K 9.28K 9.28K n/a n/a n/a
Gross Profit
1.86M 2.58M 2.5M 2.52M 2.52M 2.44M 2.54M 2.35M 2.15M 1.91M 1.69M 1.53M 1.47M 1.35M 1.15M 979.42K 746.09K 571.41K
Operating Income
-3.27M -3.88M -4.2M -4.36M -5.01M -4.87M -4.52M -4.82M -4.52M -6.01M -6.72M -7.03M -7.56M -6M -5.75M -5.09M -14.22M -14.08M
Interest Income
186.59K 215.8K 249.86K 281.75K 312.25K 374.9K 355.76K 351.81K 305.49K 195.35K 167.15K 116.79K 99.34K 104.11K 100.47K 92.15K 89.06K 96.95K
Pretax Income
-3.08M -3.67M -3.96M -4.08M -4.7M -4.47M -4.14M -4.45M -4.19M -5.82M -6.55M -6.91M -7.46M -5.89M -5.65M -5M -14.13M -13.98M
Net Income
-3.08M -3.67M -3.96M -4.08M -4.7M -4.47M -4.08M -4.29M -3.99M -5.58M -6.33M -6.78M -7.38M -5.84M -5.65M -5M -11.21M -11.06M
Selling & General & Admin
2.77M 3.24M 3.42M 3.66M 3.65M 3.47M 3.56M 3.47M 3.59M 3.67M 3.65M 3.77M 3.86M 3.72M 3.74M 3.65M 3.51M 3.4M
Research & Development
2.95M 3.22M 3.29M 3.22M 3.87M 3.84M 3.49M 3.71M 3.09M 4.26M 4.77M 4.81M 5.19M 3.64M 3.16M 2.43M 2.22M 2M
Other Expenses
n/a n/a n/a 404.00 -262 -262 4.26K 4.84K 3.8K 2.72K -1.6K 320.00 -880 434.00 1.12K -2.92K 572.00 526.00
Operating Expenses
5.71M 6.46M 6.7M 6.88M 7.53M 7.31M 7.06M 7.18M 6.68M 7.94M 8.42M 8.58M 9.04M 7.36M 6.91M 6.07M 5.72M 5.4M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.71M 6.46M 6.7M 6.88M 7.53M 7.31M 7.06M 7.18M 6.68M 7.94M 8.42M 8.58M 9.04M 7.36M 6.91M 6.07M 5.72M 5.4M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -58.62K -158.5K -202.27K -233.12K -226.51K -126.63K -82.86K -52.01K n/a 2.92K -2.92M -2.92M
Shares Outstanding (Basic)
1.54M 1.54M 1.54M 1.54M 1.54M 1.54M 1.54M 1.53M 1.52M 1.52M 1.52M 1.27M 1.27M 1.27M 1.02M 1.02M 851.29K 874.63K
Shares Outstanding (Diluted)
1.54M 1.54M 1.54M 1.54M 1.54M 1.54M 1.54M 1.53M 1.52M 1.52M 1.52M 1.27M 1.27M 1.27M 1.02M 1.02M 874.67K 874.63K
EPS (Basic)
-2 -2.38 -2.57 -2.65 -3.06 -2.92 -2.67 -2.82 -2.73 -4.12 -4.8 -5.69 -6.42 -5.64 -5.97 -5.76 -16.44 -16.66
EPS (Diluted)
-2 -2.38 -2.57 -2.65 -3.06 -2.92 -2.67 -2.82 -2.73 -4.12 -4.8 -5.69 -6.42 -5.61 -5.94 -5.73 -16.41 -16.66
EBITDA
-3.27M -3.88M -4.2M -4.36M -5.01M -4.87M -4.52M -4.81M -4.51M -5.99M -6.69M -7.02M -7.54M -5.98M -5.72M -5.07M -4.96M -4.82M
EBIT
-3.23M -3.88M -4.2M -4.36M -5.01M -4.87M -4.52M -4.82M -4.52M -6.01M -6.72M -7.03M -7.56M -6M -5.75M -5.09M -4.98M -4.83M
Depreciation & Amortization
n/a n/a -10.62K -18.47K -10.83K -7.98K 15.57K 41.62K 41.93K 48.69K 45.24K 36.33K 37.41K 36.54K 35.48K 34.24K 31.48K 29.84K